Growth Metrics

Biomerica (BMRA) Cash from Investing Activities Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Biomerica 7.12 Mn 5.78 Mn -44,000.00 -

Historic Data

Download Data 🔒
DateValue
Feb 28, 2025 75.00%
May 31, 2024 -71.43%
Feb 29, 2024 -166.67%
Nov 30, 2023 50.00%
Aug 31, 2023 -85.29%
May 31, 2023 41.71%
Feb 28, 2023 68.18%
Nov 30, 2022 51.63%
Aug 31, 2022 56.14%
May 31, 2022 66.62%
Feb 28, 2022 81.25%
Nov 30, 2021 -63.44%
Aug 31, 2021 16.42%
May 31, 2021 -6.95%
Feb 28, 2021 -231.53%
Nov 30, 2020 -329.97%
Aug 31, 2020 -549.89%
May 31, 2020 -29.52%
Feb 29, 2020 11.21%
Nov 30, 2019 71.08%
Aug 31, 2019 76.45%
May 31, 2019 7.33%
Feb 28, 2019 -59.76%
Nov 30, 2018 25.91%
Aug 31, 2018 -203.42%
May 31, 2018 -22,139.68%
Feb 28, 2018 69.52%
May 31, 2017 98.96%
Feb 28, 2017 -68.21%
May 31, 2016 -1,183.40%
Feb 29, 2016 -4,170,300.00%
Nov 30, 2015 -23.14%
Aug 31, 2015 -220.00%
May 31, 2015 98.86%
Feb 28, 2015 100.00%
Nov 30, 2014 74.56%
Aug 31, 2014 79.67%
May 31, 2014 -2,041.94%
Feb 28, 2014 -379.12%
Nov 30, 2013 57.61%
Aug 31, 2013 86.61%
May 31, 2013 -110.66%
Feb 28, 2013 93.71%
Nov 30, 2012 -1,699.65%
Aug 31, 2012 -1.11%
May 31, 2012 129.03%
Feb 29, 2012 -149.20%
Nov 30, 2011 90.73%
Aug 31, 2011 -104.17%